| Code No. | U-V002-01 | |
| Recombinant human VWF-A1 domain (residues 1261-1468 VWD type 2B) | ||
Only available for the customers in Singapore, Taiwan and South Korea Storage and Stability:VWF-A1 should be stored at -80℃ (stable for at least 1 year). The buffer contains 25 mM tris 350 mM NaCl pH 7.8 without preservative. After thawing it should be stored in appropriate small aliquots at -20℃ or -80℃ (stable for at least 2 months). For maximal stability the concentration NaCl should be at least 100 mM. Production platform: HEK293 cells using the rPEx™ recombinant protein production platform. Datasheet URL: https://products.ipatherapeutics.com/product/v002/https://www.avsbio.com/antibodies-proteins/vwf-a1-domain-human-residues-1261-1468-vwd-type-2b-recombinant/>https://www.avsbio.com/antibodies-proteins/vwf-a1-domain-human-residues-1261-1468-vwd-type-2b-recombinant |
||
| Size | 100 µg | |
| Availability (in Japan) | 0 (Contact us) (In Japan at 00:05, Feb 18, 2026 in JST) |
|
| Storage temp. | -80°C | |
| Manufacturer | AVS Bio Netherlands B.V. | |
| Alternative names | Von Willebrand antigen II, Von Willebrand Factor, F8VWF | |
| Background | Product description: Human Von Willebrand Factor (VWF) is a multimeric glycoprotein, which is involved in binding coaggulaion factor VIII and in adhesion of platelets at sites of vascular damage. In this process the platelet receptor glycoprotein Ib-IX-V complex binds to the VWF-A1 domain. The VWF-A1 variant in this product contains Von Willebrand Disease type 2B mutation R1306Q, which induces spontaneous binding of the VWF-A1 domain to platelet receptor GpIb-IX-V complex. Residues 1261-1468 of human VWF containing mutation R1306Q were cloned, the protein was over-expressed and was purified to homogeneity. The calculated molecular weight of recombinant human VWF-A1 domain is 23.8 kDa. Reference sequences: Swiss-prot P04275 |
|
| Product category | Tools:Others | |
Copyright (C)2015 Medical & Biological Laboratories Co., Ltd. All Rights Reserve